Pharmacokinetic Drug–Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients
Anti-epileptic drugs (AEDs) are an important group of drugs of several generations, ranging from the oldest phenobarbital (1912) to the most recent cenobamate (2019). Cannabidiol (CBD) is increasingly used to treat epilepsy. The outbreak of the SARS-CoV-2 pandemic in 2019 created new challenges in t...
Main Authors: | Marta Karaźniewicz-Łada, Anna K. Główka, Aniceta A. Mikulska, Franciszek K. Główka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/17/9582 |
Similar Items
-
Cannabidiol (CBD) as a Promising Anti-Cancer Drug
by: Emily S. Seltzer, et al.
Published: (2020-10-01) -
Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
by: Joshua D. Brown, et al.
Published: (2019-07-01) -
New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (AEDs)
by: Karina Sommerfeld-Klatta, et al.
Published: (2020-11-01) -
Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats
by: Kelly A. Deabold, et al.
Published: (2019-10-01) -
Population pharmacokinetic of antiepileptic drugs in different populations
by: Milovanovic Jasmina, et al.
Published: (2013-08-01)